Literature DB >> 17765730

Neurotrophins in the dentate gyrus.

Devin K Binder1.   

Abstract

Since the discovery of nerve growth factor (NGF) in the 1950s and brain-derived neurotrophic factor (BDNF) in the 1980s, a great deal of evidence has mounted for the roles of neurotrophins (NGF; BDNF; neurotrophin-3, NT-3; and neurotrophin-4/5, NT-4/5) in development, physiology, and pathology. BDNF in particular has important roles in neural development and cell survival, as well as appearing essential to molecular mechanisms of synaptic plasticity and larger scale structural rearrangements of axons and dendrites. Basic activity-related changes in the central nervous system (CNS) are thought to depend on BDNF modulation of synaptic transmission. Pathologic levels of BDNF-dependent synaptic plasticity may contribute to conditions such as epilepsy and chronic pain sensitization, whereas application of the trophic properties of BDNF may lead to novel therapeutic options in neurodegenerative diseases and perhaps even in neuropsychiatric disorders. In this chapter, I review neurotrophin structure, signal transduction mechanisms, localization and regulation within the nervous system, and various potential roles in disease. Modulation of neurotrophin action holds significant potential for novel therapies for a variety of neurological and psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17765730     DOI: 10.1016/S0079-6123(07)63022-2

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  14 in total

Review 1.  Preclinical studies modeling deep brain stimulation for depression.

Authors:  Clement Hamani; José N Nobrega
Journal:  Biol Psychiatry       Date:  2012-06-29       Impact factor: 13.382

2.  Neurotrophin-3 mRNA a putative target of miR21 following status epilepticus.

Authors:  Rashmi M Risbud; Carolyn Lee; Brenda E Porter
Journal:  Brain Res       Date:  2011-09-24       Impact factor: 3.252

3.  2014 Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression.

Authors:  Aristea S Galanopoulou; Michael Wong; Devin Binder; Adam L Hartman; Elizabeth M Powell; Avtar Roopra; Richard Staba; Annamaria Vezzani; Brandy Fureman; Ray Dingledine
Journal:  Epilepsy Curr       Date:  2016 May-Jun       Impact factor: 7.500

4.  Increased precursor microRNA-21 following status epilepticus can compete with mature microRNA-21 to alter translation.

Authors:  Kayam Chak; Biswajoy Roy-Chaudhuri; Hak Kyun Kim; Kayla C Kemp; Brenda E Porter; Mark A Kay
Journal:  Exp Neurol       Date:  2016-10-08       Impact factor: 5.330

5.  Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury.

Authors:  Xiyong Fan; Annemieke Kavelaars; Cobi J Heijnen; Floris Groenendaal; Frank van Bel
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

Review 6.  Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction.

Authors:  Ethan M Goldberg; Douglas A Coulter
Journal:  Nat Rev Neurosci       Date:  2013-04-18       Impact factor: 34.870

7.  BDNF-TrkB signaling pathway mediates the induction of epileptiform activity induced by a convulsant drug cyclothiazide.

Authors:  Yun Wang; Jin-Shun Qi; Shuzhen Kong; Yajie Sun; Jing Fan; Min Jiang; Gong Chen
Journal:  Neuropharmacology       Date:  2009-04-22       Impact factor: 5.250

8.  Nitric oxide regulates activity-dependent neuroprotective protein (ADNP) in the dentate gyrus of the rodent model of kainic acid-induced seizure.

Authors:  Anna S Cosgrave; Jennifer S McKay; Richard Morris; John P Quinn; Thimmasettappa Thippeswamy
Journal:  J Mol Neurosci       Date:  2009-01-07       Impact factor: 3.444

9.  BDNF-TrkB signaling pathway is involved in pentylenetetrazole-evoked progression of epileptiform activity in hippocampal neurons in anesthetized rats.

Authors:  Xu Liu; Jia Liu; Juan Liu; Xiao-Ling Liu; Ling-Yan Jin; Wei Fan; Jin Ding; Li-Chao Peng; Yun Wang; Xin Wang
Journal:  Neurosci Bull       Date:  2013-04-02       Impact factor: 5.203

Review 10.  Postnatal neurogenesis as a therapeutic target in temporal lobe epilepsy.

Authors:  Helen E Scharfman; Daniel P McCloskey
Journal:  Epilepsy Res       Date:  2009-04-14       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.